Akintunde Bello
Board Member
Xilio Therapeutics, Inc. (XLO)Equibles does not estimate personal net worth.
Get an email with a short summary when Xilio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get XLO alertsAbout Akintunde Bello
Akintunde Bello is recorded as Board Member at Xilio Therapeutics, Inc. (XLO). The newest filing on record that lists Akintunde Bello as Board Member at Xilio Therapeutics, Inc. (XLO) is dated April 28, 2026. Xilio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Xilio Therapeutics, Inc. includes René Russo (CEO and Board Member), Sara M. Bonstein (Chairman and Board Member), Kevin Brennan (CFO and Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at Xilio Therapeutics, Inc.
- René Russo CEO, Board Member
- Sara M. Bonstein Chairman, Board Member
- Kevin Brennan CFO, Chief Accounting Officer
- Christopher Frankenfield COO
- Akintunde Bello, Ph.D. Board Member
- Aoife Brennan Board Member
- Aoife Brennan, M.D. Board Member
- Cheryl Blanchard Board Member
- Cheryl R. Blanchard, Ph.D. Board Member
- Daniel Curran Board Member
Recent activity
No call appearances or filed executive changes recorded yet.